Headquartered in Rockville, MD, Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).

Supernus is developing medicines that improve patient compliance, decrease the occurrence of side effects, and address unmet medical needs.

Our heritage of more than 15 years in the successful development of products that are enabled by our innovative technologies has yielded a robust pipeline of differentiated CNS products with lower risk, large market potential, shorter timeline to market, and value creation through new intellectual property.

Our vision is to be a leading neuroscience specialty pharmaceutical company developing and marketing proprietary products. We plan on building our commercial organization with dedicated sales force for the neurology and psychiatry specialty areas. We will seek partners for primary care, other specialty areas and ex-US markets.